Bristol Highlights Growth Is Not Coming From Opdivo Alone

Spectrum of stacked multi-colored wooden blocks
Bristol believes its Celgene products and pipeline assets are helping to diversify its revenue • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business